Noninvasive Brain Control Is Real — and That’s Good
You might think you don’t want anyone controlling your brain. You might think that anyone who did want to control your brain was behaving, you know, invasively. But you’d be wrong — and that’s actually very good news.
MoreIsrael Launches Series of Airstrikes in Gaza Strip NBC NewsRuth Bader Ginsburg Writes Scathing 35-Page Dissent In Birth Control Case Huffington PostWhy It's No Shock Facebook Secretly Toyed With Users' Emotions NBC NewsSevere Storms Batter Midwest as Flooding Risk Rises NBC NewsUruguay eliminates Italy; Did Suarez bite again? Sports IllustratedMost of the reactions in your brain are me...
Source: TIME: Top Science and Health Stories - June 30, 2014 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized brain control epilepsy Genetic Engineering opsins optogenetics the brain Source Type: news
Noninvasive Brain Control Is Real—and That’s Good
You might think you don’t want anyone controlling your brain. You might think that anyone who did want to control your brain was behaving, you know, invasively. But you’d be wrong—and that’s actually very good news.
MoreTragic Discovery: Israel Army Reports Bodies of Missing Teens Found NBC NewsWorld Cup's Muslim Players Face Big Challenge With Ramadan Fast Huffington PostGM to Offer Victims' Families at Least $1 Million NBC NewsRob Ford Returns: Out of Rehab and Back to Work NBC NewsUruguay eliminates Italy; Did Suarez bite again? Sports IllustratedMost of the reactions in your brain are mediated eithe...
Source: TIME: Top Science and Health Stories - June 30, 2014 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized brain control epilepsy Genetic Engineering opsins optogenetics the brain Source Type: news
University of Utah ophthalmologist receives $100,000 from Research to Prevent Blindness
(University of Utah Health Sciences) Research to Prevent Blindness, a New York-based foundation, has announced that University of Utah researcher Wolfgang Baehr, Ph.D., will receive the Nelson Trust Award for Retinitis Pigmentosa -- and an accompanying $100,000 to pursue new scientific leads to understand contributors to blindness. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2014 Category: Global & Universal Source Type: news
Salvaging Ruins: Reverting Blind Retinas into Functional Visual Sensors
Blindness is one of the most devastating conditions affecting the quality of life. Hereditary degenerative diseases, such as retinitis pigmentosa, are characterized by the progressive loss of photoreceptors, leading to complete blindness. No treatment is known, the current state-of-the-art of restoring vision are implanted electrode arrays. As a recently discovered alternative, optical neuromodulators, such as channelrhodopsin, allow new strategies for treating these diseases by imparting light-sensitivity onto the remaining retinal neurons after photoreceptor cell death. Retinal degeneration is a heterogeneous set of dise...
Source: Springer protocols feed by Protein Science - April 11, 2014 Category: Biochemistry Source Type: news
Spark And Genable Tech Collaborate On Rare Gene Therapy
Spark Therapeutics and Genable Technologies announced that they have signed a collaboration agreement to develop GT038, Genable’s lead therapeutic drug for the treatment of rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - March 26, 2014 Category: Pharmaceuticals Source Type: news
Newly developed chemical restores light perception to blind mice
Progressive degeneration of photoreceptors -- the rods and cones of the eyes -- causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. The compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 19, 2014 Category: Science Source Type: news
Patients with rare sight disorder get vision partly restored via gene therapy
Oxford trial that improved vision in choroideremia raises hopes gene therapy may be applied to common causes of blindnessTwo men with progressive blindness have regained some of their vision after taking part in the first clinical trial of a gene therapy for the condition.The men were among six patients to have experimental treatment for a rare, inherited, disorder called choroideremia, which steadily destroys eyesight and leaves people blind in middle age.After therapy to correct a faulty gene, the men could read two to four more lines on an optician's sight chart, a dramatic improvement that has held since the doctors tr...
Source: Guardian Unlimited Science - January 16, 2014 Category: Science Authors: Ian Sample Tags: The Guardian Genetics Doctors News Health Medical research UK news Disability Blindness and visual impairment Science Source Type: news
Beta-Carotene: Any Benefit for Retinitis Pigmentosa?Beta-Carotene: Any Benefit for Retinitis Pigmentosa?
A study seeks to find out whether beta-carotene can restore retinal function in patients with this devastating condition. Medscape Optometry (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - January 6, 2014 Category: Opthalmology Tags: Ophthalmology Viewpoint Source Type: news
Schizophrenia and retinitis pigmentosa: Are there mechanisms which blind insanity? - Narayanaswamy JC, Viswanath B, Bada Math S.
[Abstract unavailable]
Language: Eng... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - November 19, 2013 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Prosthesis Improves Vision in Retinitis PigmentosaProsthesis Improves Vision in Retinitis Pigmentosa
Patients using the prosthetic retina could better identify objects, leading to an improved quality of life. Medscape Medical News (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - November 19, 2013 Category: Opthalmology Tags: Ophthalmology News Source Type: news
New device offers hope to people blinded due to incurable eye disorders
(American Academy of Ophthalmology) Research presented today at the 117th Annual Meeting of the American Academy of Ophthalmology shows promising data about a device that helps people who have lost their vision due to a blinding genetic disease to recognize common objects. In the study, the researchers found when the objects' outlines had been enhanced, there was increased recognition. The device, called the Argus II, is the first FDA-approved retinal implant for adults with retinitis pigmentosa. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2013 Category: Global & Universal Source Type: news
'Bionic eye' tops Top 10 for 2014
A “bionic eye” and an implantable “defibrillator for epileptics” are #1 and #3 on the Cleveland Clinic’s Top 10 Innovations for 2014 announced at last week's Cleveland Clinic Innovation Summit.
The bionic eye, otherwise known as a retinal prosthesis, received FDA approval this year and will be used to treat patients with vision loss from Retinitis Pigmentosa (RP), a group of inherited diseases that damage the rods and cones of the retina. In healthy eyes, these rods and cones that function as specialized cells to convert light into electromechanical impulses that are sent via the optic nerve into the brain, where...
Source: Articles from MedicalDesign.com - October 22, 2013 Category: Medical Equipment Tags: News Source Type: news
Retinitis pigmentosa identified by simple blood or urine test
Research led by physician-scientists at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has produced a breakthrough discovery in diagnosing retinitis pigmentosa, a blinding disease that affects about 1 in 4,000 people in the United States. Rong Wen, M.D., Ph.D., and Byron Lam, M.D., professors of ophthalmology at Bascom Palmer, in collaboration with biochemist Ziqiang Guan, Ph.D... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 16, 2013 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news
Simple blood or urine test to identify blinding disease
(University of Miami) Research led by physician-scientists at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has produced a breakthrough discovery in diagnosing retinitis pigmentosa, a blinding disease that affects about 1 in 4,000 people in the United States. Two UM professors of ophthalmology and a Duke professor discovered a key marker in blood and urine that can id people who carry genetic mutations in a gene responsible for retinitis pigmentosa. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 14, 2013 Category: Global & Universal Source Type: news
Retinitis pigmentosa test identifies mutation found in Ashkenazi Jewish population
You might not think to look to a urine test to diagnose an eye disease. But a new Duke University study says it can link what is in a patient's urine to gene mutations that cause retinitis pigmentosa, or RP, an inherited, degenerative disease that results in severe vision impairment and often blindness. The findings appear online in the Journal of Lipid Research. "My collaborators, Dr. Rong Wen and Dr... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 11, 2013 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news
